The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 268.6M (2022) → 739.8M (2026)
Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+231.4% YoY
YoY Growth Rate
Revenue accelerating
+0.0% YoY
YoY Growth Rate
Slow EPS growth
A$531,130/ year
↓ Declining (-35% vs prior year)
13.7% of revenue
Below sector average (18%)
R&D spend declining — could signal cost-cutting or efficiency
~8 months
A$8M cash & investments
Quarterly Free Cash Flow
→ Burn rate stable
Short runway — potential dilution ahead through share issuance
Emyria Limited grew revenue 231% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
Negative ROIC means the business is losing money on every dollar invested in it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Free cash flow is negative. They are burning cash, not generating it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
